CAR-T Therapy Shows Great Success in Treating Lymphoma

Since its FDA approval in 2017, CAR-T therapy has shown great promise in effectively treating challenging cancer types, like large B-cell lymphoma. Exciting new research backs up that initial assessment, as revealed at a recent meeting of the American Society of Hematology. The data comes from two biopharmaceutical companies – Kite Pharma and Bristol Myers […]

An Alarm System for CRISPR Gene Editing

CRISPR gene-editing technology could help solve many of the world’s most pressing challenges. Bio-energy crops that can survive drought conditions? CRISPR may be the solution. Bacteria that turns biomass into sustainable aviation fuel? Ditto. But scientists using the technique face a problem – how can they tell if the gene edits they think they’ve made […]